| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8775424 | Urology | 2018 | 13 Pages |
Abstract
Mirabegron monotherapy in male patients with OAB and BOO was safe. However, the storage symptoms improvement was less in patients with BOO and AEs rate was higher.
Related Topics
Health Sciences
Medicine and Dentistry
Nephrology
Authors
Chun-Hou Liao, Hann-Chorng Kuo,